1991
DOI: 10.1590/s0074-02761991000300011
|View full text |Cite
|
Sign up to set email alerts
|

Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic cuban epidemic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
22
0
1

Year Published

1999
1999
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 0 publications
2
22
0
1
Order By: Relevance
“…Primary infection with any of the four serotypes results in lifelong immunity to the same serotype but leaves the individual susceptible to sequential secondary infections by heterologous serotypes (7). Epidemiological studies in Cuba and Southeast Asia have shown a strong association between secondary dengue infection and DHF (8,9). These data indicate that previous immunity to dengue may be a risk factor in the development of severe dengue disease (10,11).…”
mentioning
confidence: 97%
“…Primary infection with any of the four serotypes results in lifelong immunity to the same serotype but leaves the individual susceptible to sequential secondary infections by heterologous serotypes (7). Epidemiological studies in Cuba and Southeast Asia have shown a strong association between secondary dengue infection and DHF (8,9). These data indicate that previous immunity to dengue may be a risk factor in the development of severe dengue disease (10,11).…”
mentioning
confidence: 97%
“…The pathogenesis of DHF/DSS is not well understood, but epidemiological observations suggest that severe disease occurs more frequently in the setting of secondary infection with heterologous dengue virus serotypes (11,25). Ennis and coworkers (15,21) have proposed a model for the immunopathogenesis of DHF/DSS in which dengue virus-specific memory T cells from a previous infection are activated by infected monocytes or macrophages via major histocompatibility complex (MHC)-restricted presentation of heterologous dengue virus epitopes to produce cytokines, including gamma interferon (IFN-␥), which upregulate expression of cell surface Fc␥R.…”
mentioning
confidence: 99%
“…there is no cross-immunity of serotypes, except in the course of the first weeks or months following the infection (Martínez, 1998). However, when a person has sub-neutralizing Ig against one of the dengue viruses and is infected by another viral serotype, an infrequent response is produced, one that is almost exclusive of the infection by dengue: an antibody-dependent amplification (ada) that is expressed in an enhanced viral replication and an increase in the viremia, which promotes and favors the development of the severe form of the illness (Guzmán et al, 1992;Halstead, 2002).…”
mentioning
confidence: 99%